Vimarsana
Biggest News Aggregation in the World

88033g40 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 88033g40. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 88033g40 Today - Breaking & Trending Today

UBS Group Increases Tenet Healthcare (NYSE:THC) Price Target to $150.00 - Vimarsana News

UBS Group Increases Tenet Healthcare (NYSE:THC) Price Target to $150.00

Tenet Healthcare (NYSE:THC – Free Report) had its price target raised by UBS Group from $137.00 to $150.00 in a research report report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also issued reports about the stock. Deutsche Bank Aktiengesellschaft upped their price objective […]

Truist Financial Reiterates "Buy" Rating for Tenet Healthcare (NYSE:THC) - Vimarsana News

Truist Financial Reiterates "Buy" Rating for Tenet Healthcare (NYSE:THC)

Truist Financial reaffirmed their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $130.00 target price on the stock, up from their prior target price of $120.00. A number of other brokerages also recently commented on THC. Wells Fargo & Company […]

Royal Bank of Canada Raises Tenet Healthcare (NYSE:THC) Price Target to $136.00 - Vimarsana News

Royal Bank of Canada Raises Tenet Healthcare (NYSE:THC) Price Target to $136.00

Tenet Healthcare (NYSE:THC – Free Report) had its target price lifted by Royal Bank of Canada from $109.00 to $136.00 in a report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. THC has been the subject of a number of other reports. UBS Group upped […]

Tenet Healthcare (NYSE:THC) PT Raised to $136.00 - Vimarsana News

Tenet Healthcare (NYSE:THC) PT Raised to $136.00

Tenet Healthcare (NYSE:THC – Free Report) had its price target increased by Royal Bank of Canada from $109.00 to $136.00 in a report released on Wednesday, Benzinga reports. They currently have an outperform rating on the stock. THC has been the topic of a number of other research reports. UBS Group boosted their price objective […]

Source: wkrb13.com
Tenet Healthcare (NYSE:THC) PT Raised to $147.00 at Barclays - Vimarsana News

Tenet Healthcare (NYSE:THC) PT Raised to $147.00 at Barclays

Tenet Healthcare (NYSE:THC – Get Free Report) had its target price lifted by investment analysts at Barclays from $113.00 to $147.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective indicates a potential upside of 22.21% from the stock’s current […]